BioSpace News Archive

Business

Progressive Care to Host Conference Call on the 2019 3rd Quarterly Filing and Business Update on November 14th, 2019

Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Thursday, November 14th, 2019.

November 7, 2019
·
3 min read
BioMidwest

Braun Industries Inc. adds Siddons-Martin Emergency Group to its Dealer Network

Braun Industries Inc., an industry leader in the global ambulance manufacturing market, welcomes industry leading, Siddons-Martin Emergency Group, as their new Braun dealer for Texas, New Mexico and Louisiana.

November 7, 2019
·
2 min read
Business

10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue GuidanceQ3 2019 revenue growth of 67% over prior year period

10x Genomics, Inc., reported financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
8 min read
Business

Tabula Rasa HealthCare Announces Third Quarter 2019 Operating ResultsThird Quarter 2019 Revenue of $74.3 million, growth of 36%

Tabula Rasa HealthCare, Inc., a healthcare technology company advancing the field of medication safety, announced its financial results for the third quarter ended September 30, 2019.

November 7, 2019
·
20 min read
Business

Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs

Multiple first- or best-in-class drug candidates, skilled leadership team and liquidity position of approximately $1.2 billion

November 7, 2019
·
9 min read
Business

Sarepta Therapeutics Announces Third Quarter 2019 Financial Results and Recent Corporate Developments

Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, reported financial results for the third quarter of 2019.

November 7, 2019
·
26 min read
Business

MEI Pharma Reports First Quarter Fiscal Year 2020 Results and Operational Highlights

ME-401 emerging as potential best-in-class PI3K delta inhibitor, with Phase 2 study intended to support accelerated approval with FDA in follicular lymphoma underway

November 7, 2019
·
6 min read
Business

Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update

Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, reported financial results for the three and nine months ended September 30, 2019 and provided a business update.

November 7, 2019
·
7 min read
Business

Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Proteostasis Therapeutics, Inc. announced financial results for the third quarter ended September 30, 2019 and provided a corporate update.

November 7, 2019
·
8 min read
Business

Syndax Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Business Update

E2112 trial passed final interim OS analysis; trial continues, with final OS analysis expected in 2Q20

November 7, 2019
·
9 min read